The ability of K331 to undergo such diverse modifications underscores its critical role in modulating tau's behavior and highlights the complex regulatory mechanisms that govern the involvement of tau in AD and other neurodegenerative diseases involving tauopathies. The gene discussed is MAPT; the disease is tauopathy.